Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Scientific Reports|January 19, 2019
A 14-day repeat dose oral gavage range-finding study of a first-in-class CDI investigational antibiotic, in ratsKatherine Sibley, Jayson Chen, Lee Koetzner, et al.
The Journal of Endocrinology|January 7, 2014
Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker ratsRaylene A Reimer, Gary J Grover, Lee Koetzner, et al.
Nutrition Research (New York, N.Y.)|May 3, 2011
The soluble fiber complex PolyGlycopleX lowers serum triglycerides and reduces hepatic steatosis in high-sucrose-fed ratsRaylene A Reimer, Gary J Grover, Lee Koetzner, et al.
Life Sciences|December 1, 2010
Effects of the soluble fiber complex PolyGlycopleX® (PGX®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic ratsGary J Grover, Lee Koetzner, Joan Wicks, et al.
The Journal of Nutrition|August 24, 2012
Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker ratsRaylene A Reimer, Gary J Grover, Lee Koetzner, et al.
Frontiers in Pharmacology|September 17, 2011
Effects of the Soluble Fiber Complex PolyGlycopleX on Glucose Homeostasis and Body Weight in Young Zucker Diabetic RatsGary James Grover, Lee Koetzner, Joan Wicks, et al.
Journal of Pharmacological and Toxicological Methods|November 22, 2015
Robustness of arterial blood gas analysis for assessment of respiratory safety pharmacology in ratsGarth T Whiteside, Michele Hummel, Jamie Boulet, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 4, 2018
Absence of adverse effects following the gavage administration of methyl propyl trisulfide to Sprague-Dawley rats for 90 daysMaria Bastaki, Michel Aubanel, Thierry Cachet, et al.
Neuropharmacology|April 9, 2005
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsyKenneth J Valenzano, Laykea Tafesse, Gary Lee, et al.
Molecular Therapy. Advances|July 9, 2026
Intra-CNS AAV9-GBA1 delivery yields species and route of administration differences in safety and transgene expressionAna Claudia Amaral, Branka Grubor, Davide Gianni, et al.
Pageof 2